KIT and thymic carcinoma: When distinguishing thymic carcinomas from lung primary squamous carcinomas, determining PAX8, CD5, and CD117 positivity in thymic carcinomas can be useful to distinguish thymic carcinomas from metastatic carcinomas [43].